RELMADA THERAPEUTICS, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RELMADA THERAPEUTICS, INC. stock issued during period, shares, new issues for the quarter ending 2018-06-30 was -12.36K shares.
- RELMADA THERAPEUTICS, INC. stock issued during period, shares, new issues for the quarter ending 2018-03-31 was 100.00 shares.
- RELMADA THERAPEUTICS, INC. stock issued during period, shares, new issues for the quarter ending 2017-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- RELMADA THERAPEUTICS, INC. stock issued during period, shares, new issues for the quarter ending 2017-09-30 was 16.70K shares, a 92.41% decline year-over-year.
- RELMADA THERAPEUTICS, INC. stock issued during period, shares, new issues for fiscal 2021 was 0.00 shares, a 100.00% decline from fiscal 2020.
- RELMADA THERAPEUTICS, INC. stock issued during period, shares, new issues for fiscal 2020 was 42.48K shares.
- RELMADA THERAPEUTICS, INC. stock issued during period, shares, new issues for fiscal 2019 was 24.99K shares, a 463.24% increase from fiscal 2018.
- RELMADA THERAPEUTICS, INC. stock issued during period, shares, new issues for fiscal 2018 was 4.44K shares, a 99.09% decline from fiscal 2017.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2021-12-31 | 0.00 shares 10-K · filed 2022-03-25 | |
| 2020-12-31 | 42.48K shares 10-K · filed 2022-03-25 | |
| 2019-06-30 | 24.99K shares 10-K · filed 2021-03-24 | |
| 2018-06-30 | -12.36K shares derived: 10-KT 12 month − 10-Q 9 month · filed 2020-03-26 | 4.44K shares 10-KT · filed 2020-03-26 |
| 2018-03-31 | 100.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | |
| 2017-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-12 | |
| 2017-09-30 | 16.70K shares 10-Q · filed 2017-11-14 | |
| 2017-06-30 | 487.21K shares 10-K · filed 2018-09-28 | |
| 2016-12-31 | 874.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | |
| 2016-09-30 | 220.00K shares 10-Q · filed 2016-11-10 | |
| 2016-03-31 | 1.09M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |